Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on June 24, 2025
InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke
GlobeNewswire
·
June 24, 2025
MIAMI, June 24, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (the “Company”) (Nasdaq: NSPR), developer of the CGuard Prime Carotid Stent System for the prevention of stroke, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket …
BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & Related Disorders® Congress
GlobeNewswire
·
June 24, 2025
CARSON CITY, Nev., June 24, 2025 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver …
Corbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity Symposium
GlobeNewswire
·
June 24, 2025
NORWOOD, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a fire side chat at the …
Syndax Announces FDA Priority Review of sNDA for Revuforj® (revumenib) in Relapsed or Refractory mNPM1 Acute Myeloid Leukemia
GlobeNewswire
·
June 24, 2025
– PDUFA action date set for October 25, 2025 – – sNDA being reviewed under FDA’s RTOR program – – Revumenib has the potential to become the first and only menin inhibitor approved in both R/R mNPM1 AML and R/R KMT2Ar acute leukemia – NEW YORK, June 24, …
Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions
GlobeNewswire
·
June 24, 2025
CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) -- Abvance Therapeutics, a biotechnology company developing next-generation glucagon analogs and therapies to prevent hypoglycemia and improve glucose management, today announced the closing of its initial seed …
Virginia Beach Boy Shot in Head Finds Road to Recovery at Children's Hospital of The King's Daughters
GlobeNewswire
·
June 24, 2025
Norfolk, Virginia, June 24, 2025 (GLOBE NEWSWIRE) -- NORFOLK, Va. – Emily Rigsby and Steven Davis sat next to their son, Landyn, in the pediatric intensive care unit desperately watching for any sign that he would be OK. The 8-year-old had been playing …
Shiny Smile Veneers Named Top Snap-On Veneer Brand in the US by Independent Review Platforms
GlobeNewswire
·
June 24, 2025
Houston, TX, June 24, 2025 (GLOBE NEWSWIRE) -- Shiny Smile Veneers, a US-based provider of custom-made snap-on veneers, has once again been recognized as one of the top snap-on veneer brands in the country, this time by two leading dental product resources …
Carestream Demonstrates Commitment to Sustainability with Better Stands Silver Award at Hospitalar 2025
GlobeNewswire
·
June 24, 2025
SÃO PAULO, June 24, 2025 (GLOBE NEWSWIRE) -- Carestream Health was honored with the Better Stands Silver Award at Hospitalar 2025, recognizing the company’s efforts towards sustainability and reducing its environmental footprint by implementing a reusable …
Three New York Dispensaries Elevating Cannabis Retail Through Community and Culture
EIN Presswire
·
June 24, 2025
Dank 716, Smiley Exotics, and Nicklz Lead with Legacy, Local Engagement, and Trust in the Empire State NEW YORK, NY, UNITED STATES, June 23, 2025 /EINPresswire.com/ -- As New York’s legal cannabis market continues to grow, a small group of independent …
Creative Biolabs: Leading the Way to the Future of Immunotherapy Research with Precision and Innovation
EIN Presswire
·
June 24, 2025
Creative Biolabs is leading the way to the future of immunotherapy research with innovative tools that enable researchers to explore new ways. SHIRLEY, NY, UNITED STATES, June 24, 2025 /EINPresswire.com/ -- With increasingly advanced research, the …
Multiple Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 60+ Key Companies | DelveInsight
GlobeNewswire
·
June 24, 2025
New York, USA, June 24, 2025 (GLOBE NEWSWIRE) -- Multiple Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 60+ Key Companies | DelveInsight Multiple Sclerosis, the most common neurological disorder in young adults, with …
Lulutox Tea UK (Lulutox Tea Detox) Officially Launches in Ireland, USA, Australia & Canada for Natural Digestive Cleanse
GlobeNewswire
·
June 24, 2025
New York City, June 24, 2025 (GLOBE NEWSWIRE) -- Lulutox™, a rising name in wellness and herbal nutrition, is excited to announce the official launch of its flagship product, Lulutox Detox Tea, across international markets including Ireland, the United …
PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERING
GlobeNewswire
·
June 24, 2025
MINNEAPOLIS, June 24, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo" or the “Company”) an emerging biomedical device company focused on the …
PruittHealth Certified as a Great Place to Work®
GlobeNewswire
·
June 24, 2025
NORCROSS, Ga., June 24, 2025 (GLOBE NEWSWIRE) -- For the fourth consecutive year, PruittHealth, a leader in the Southeast for post-acute care and senior services, is officially certified as a Great Place to Work® for 2025. This prestigious recognition …
Hapbee Delivers Breakout Q1 2025: Record Growth, Leaner Operations, and a Clear Path to Scalable Profitability
GlobeNewswire
·
June 24, 2025
VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (TSXV: HAPB | OTCQB: HAPBF), (“Hapbee” or the “Company”), the digital wellness technology company pioneering the science of bio-streaming, announced today its …
Inventprise Announces Breakthrough in COVID-19 Conjugate Vaccine Study Published in Vaccine Journal
GlobeNewswire
·
June 24, 2025
REDMOND, Wash., June 24, 2025 (GLOBE NEWSWIRE) -- Inventprise, a clinical stage vaccine invention company, today announced the publication of a landmark preclinical study in Vaccine Journal (Vol. 54, April 30, 2025, Article 126988) showcasing the potential …
First Steroid Cycle 2025: Experts Discuss Science Behind Beginner’s Guide to Choise Best Steroids for Muscle Growth, Bulking & Cutting By CrazyBulk
GlobeNewswire
·
June 24, 2025
New York City, June 24, 2025 (GLOBE NEWSWIRE) -- How First-Time Users Can Build Muscle with Confidence’ Ultimate Beginner’s Guide to Steroid Cycles: Safe, Legal, and Effective Alternatives for Muscle Growth and Performance in 2025 Launches By CrazyBulk. …
National Fitness Partners Raises Over $24,000 for Make-A-Wish Foundation
GlobeNewswire
·
June 24, 2025
CAMP HILL, Pa., June 24, 2025 (GLOBE NEWSWIRE) -- National Fitness Partners (NFP), a leading Planet Fitness franchisee, is proud to announce it has raised $24,121.61 in support of Make-A-Wish Foundation, helping grant life-changing wishes for children with …
Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech
GlobeNewswire
·
June 24, 2025
CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…
Fortrea und Emery Pharma kündigen strategische Zusammenarbeit zur Durchführung FDA-konformer Arzneimittelwechselwirkungsstudien mit Rifampin an
GlobeNewswire
·
June 24, 2025
Durham, North Carolina, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (das „Unternehmen“), ein führendes globales Auftragsforschungsinstitut (Contract Research Organization CRO), hat heute eine strategische Zusammenarbeit mit Emery Pharma …